Seeking Alpha

Wyeth (WYE)

()

News & PR
Market Currents

Buzz
Twitter: WYE

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

A Look Inside Paulson's Investor Letter

Dec 3 • Market Folly • Comment!
Dan Loeb: Investment Outlook 'Favorable' Through Mid-2010

Dec 2 • Market Folly • 4 Comments
Greenlight's Einhorn Exits Energy, Focuses on Healthcare

Nov 24 • Market Folly • Comment!
What Are the Best Hedge Funds Buying Now?

Nov 19 • The Pragmatic Capitalist • 6 Comments
Q3 Portfolio Moves: Bruce Berkowitz Is Buying

Nov 19 • Davy Bui • 1 Comment
Progenics: Are the Prospects That Bad?

Nov 16 • David Greene • Comment!
Where Are the Original Dividend Aristocrats Now?

Nov 11 • Dividend Growth Investor • 10 Comments
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
TIM Report: Profit Taking Results in Less Bullish Market Sentiment

Oct 26 • David Enke • Comment!
Galleon Group's 50 Largest Holdings

Oct 18 • AlphaClone • 10 Comments
Wednesday Options Recap

Oct 14 • Frederic Ruffy • Comment!
Progenics: Investors Are Right To Be Wary

Oct 14 • EP Vantage • 1 Comment
Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet

Oct 12 • M. E. Garza • 1 Comment
Tuesday Options Update: NTRI, GFI, AUY, AA, & WYE

Oct 6 • Andrew Wilkinson • Comment!
China Biotech Week in Review: Wyeth / Pfizer Merger Allowed

Oct 4 • ChinaBio Today • Comment!
China Requires One Divestiture for Pfizer / Wyeth Merger

Oct 1 • ChinaBio Today • 1 Comment
Shumway: Another Hedge Fund Falls for BofA

Sep 30 • Market Folly • Comment!
Which Pfizer / Wyeth Sites Will Shut Down?

Sep 28 • Derek Lowe • 2 Comments
Positive Data from Wyeth Drug

Sep 18 • Zacks.com • 1 Comment
Are High Dividend Stocks a Good Investment?

Sep 16 • Dividend Growth Investor • 16 Comments
Ramius Capital Buys Drug Companies, Moves Out of ETFs

Sep 15 • Todd Walker • Comment!
Goldman Sachs Hedge Fund Trend Monitor

Sep 4 • Mebane Faber • 2 Comments
Greenlight Capital: Cautious over Q2

Sep 3 • Todd Walker • 5 Comments
Eton Park Loads Up on Options

Sep 2 • Market Folly • 3 Comments
Moore Capital Is Buying: China, Financials and Consumer Staples

Aug 20 • Todd Walker • Comment!
Pharma Majors to Gain from India's Patent Decision

Aug 19 • Zacks.com • Comment!
The Few, The Proud, The Stocks Above Pre-Lehman Levels

Aug 17 • Bespoke Investment Group • 1 Comment
PDL BioPharma: High Dividend Biotech Stock

Aug 17 • Double Dividend Stocks • 5 Comments
Atticus Capital to Close $3 Billion Fund

Aug 11 • Bespoke Investment Group • 1 Comment
Manikay Partners Buy Healthcare, Dump Financials

Aug 10 • Todd Walker • 1 Comment
Wyeth Should Be More Forthcoming with Authorship Disclosures

Aug 6 • Derek Lowe • 1 Comment
FDA Calendar Updates: ViroPharma, Electro-Optical Sciences, Wyeth, Progenics

Aug 5 • Mike Havrilla • Comment!
Time to Get Conservative? 50 Ideas for a Summer Sell-Off

Aug 3 • Marco Hickey • 16 Comments
Lines Blur Between Biotech and Pharma

Jul 28 • Vincent Fernando • Comment!
Healthcare Companies Report Growth, Surge of M&A Deals

Jul 24 • James Rickman • Comment!
Shumway Capital: A Great Fund to Investigate for Cloning

Jul 23 • Mebane Faber • Comment!
Wall Street Breakfast: Must-Know News

Jul 23 • SA Editor Rachael Granby • 18 Comments
Analyzing Earnings Quality of Companies Set to Report

Jul 23 • Value Expectations • Comment!
Merck and Glaxo Look to Benefit from WHO Recommendation

Jul 22 • Zacks.com • Comment!
Wall Street Breakfast: Must-Know News

Jul 21 • SA Editor Rachael Granby • 10 Comments
Hoping Against Hope for Wyeth / Elan Alzheimer Dug

Jul 21 • Derek Lowe • 2 Comments

Wyeth (WYE)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers